Friday, October 07, 2016 8:31:57 PM
shorts had the hardest time bringing it under 6.48.
higher highs, higher lows...
rsi from 11 to 14 since the mega slide
be in now or chase this baby on the uptick.
**************** SCREAMS RUN UP.
IMO- 7&8 are very close to becoming reality.... like in the next 20 days.
the stock is to legit to $hit on it.
SOLID after a mega slide?????? ...pffff ...yup!!!!
down 50%.... major slide from the $13 range
shorts taking less than 10% are turds....lol
but seems to me the upward trend is STILL continuing regardless.
they are reducing spending by 9 million dollars.... not cuz they died, cuz the project is BASICLY READY.
Q4 gonna read like a bible.... praise the oh mighty dolla..
also, they don't need to keep the Sweden plant open for r/d.... holy Christ the project is BASICLY FINISHED..., California can pick up the slack....ffs they only need to cool the machine...
SWEDEN BUILDING RENT IS 383,000 ....id close it too!! f'it, .
just my opinion but, 7&8 is easy, I like 9's for myself...but I'm greedy I admit,but I'm totally serious and being realistic.
Recent TRIB News
- Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates • GlobeNewswire Inc. • 04/04/2024 11:30:02 AM
- Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 03/28/2024 10:39:07 PM
- Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule • GlobeNewswire Inc. • 03/08/2024 03:03:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/15/2024 07:11:36 PM
- Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change • GlobeNewswire Inc. • 02/15/2024 05:34:50 PM
- Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change • GlobeNewswire Inc. • 02/13/2024 02:00:12 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 02/10/2024 12:51:28 AM
- Trinity Biotech to Present at Emerging Growth Conference • GlobeNewswire Inc. • 02/08/2024 01:30:00 PM
- Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code • GlobeNewswire Inc. • 02/07/2024 01:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/01/2024 04:37:17 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/01/2024 04:33:32 PM
- Trinity Biotech Announces Q3 2023 Financial Results & Business Update • GlobeNewswire Inc. • 01/31/2024 12:05:00 PM
- Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India • GlobeNewswire Inc. • 01/31/2024 12:02:00 PM
- Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc. • GlobeNewswire Inc. • 01/31/2024 12:00:00 PM
- Trinity Biotech plc to Host Investor Call • GlobeNewswire Inc. • 01/30/2024 10:23:47 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/02/2024 09:17:57 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/02/2024 09:13:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/02/2024 07:02:39 PM
- Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya • GlobeNewswire Inc. • 12/27/2023 01:57:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/19/2023 06:56:39 PM
- Trinity Biotech Announces Management Changes • GlobeNewswire Inc. • 12/18/2023 09:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/29/2023 02:00:03 PM
- Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares • GlobeNewswire Inc. • 11/28/2023 09:05:56 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/10/2023 08:05:35 PM
- Trinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To Prevent the Procurement of TrinScreen HIV By The Kenyan Ministry of Health • GlobeNewswire Inc. • 10/10/2023 12:15:38 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM